Galectin-3 Test Helps Assess Heart Failure Patients

 

March 25, 2011
Galectin-3 is a mediator of cardiac fibrosis (pictured) and adverse remodeling in heart failure patients.

A galectin-3 test helps assess the prognosis of patients with chronic heart failure. It is offered by Health Diagnostic Laboratory (HDL), using the BG Medicine Galectin-3 Test.

Elevated galectin-3 levels are associated with an inherently progressive form of heart failure that is associated with an increased risk of hospitalization or death. Galectin-3 has been implicated in a variety of biological processes important in heart failure development and progression, including fibrosis. Progressive cardiac fibrosis interferes with the cardiac pump function and increases the risk of death.

For more information: www.myhdl.com, www.galectin-3.com